MarginsXMarginsX
Home › Markets › Health Care › WWB

Windward Bio Group AG Common Shares (WWB)

WWB trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$30.04
+5.40% on the day
Market cap
$1.7B
Small cap
Revenue
No annual revenue in SEC XBRL data for this filer
Net income
No annual revenue in SEC XBRL data for this filer

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerWWB on Nasdaq
SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CountrySwitzerland
IPO year2026
SEC CIK0002145089
SEC industry codeBiological Products, (No Diagnostic Substances) (SEC code, stale: periodic reports ended never filed)
Incorporated inSwitzerland

Financials

No annual revenue in SEC XBRL data for this filer.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42026-11-16

Source: SEC EDGAR submissions feed, 24 recent filings. All filings on EDGAR.

Peers in Biotechnology: Biological Products (No Diagnostic Substances)

TickerCompanyPriceDayMarket cap
ALVOAlvotech$4.41+5.13%$1.7B
RXRXRecursion Pharmaceuticals Inc.$2.90-8.79%$1.8B
COAGHemab Therapeutics Holdings Inc.$39.05-4.42%$1.8B
VIRVir Biotechnology Inc.$9.58-3.82%$1.6B
MAZEMaze Therapeutics Inc.$33.90-1.25%$1.9B
MESOMesoblast Limited$12.45-6.18%$1.6B
BCRXBioCryst Pharmaceuticals Inc.$7.45-2.10%$1.9B
REPLReplimune Group Inc.$21.41-2.19%$2.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier